nonstatisticians

2021/12: Adaptive Design in Clinical Trials

Kaspar Rufibach, shortcourse given in collaboration with DIA

2021/11: The final word on interim analyses.

Kaspar Rufibach, Roche-internal course

2021/10: How to survive survival analysis.

Kaspar Rufibach, Roche-internal course

2021/05: Implications of the ICH E9 estimand addendum on how we develop, run, and analyse clinical trials

Kaspar Rufibach, course for clinical reviewers at ANVISA (Brazilian Health Authority)

2021/05: Introduction to statistics.

Kaspar Rufibach, Roche-internal course

2021/02: Introduction to statistics.

Kaspar Rufibach, Roche-internal course

2020/11: Introduction to statistics.

Kaspar Rufibach, Roche-internal course

2020/12: Introduction to survival analysis for rheumatology.

Kaspar Rufibach, Roche-internal course

2020/09: Introduction to survival and interim analyses.

Kaspar Rufibach, Roche-internal course

2020/08: Introduction to biostatistics.

Kaspar Rufibach, Roche-internal course